4//SEC Filing
Meeker David P 4
Accession 0001104659-25-056838
CIK 0001649904other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:16 PM ET
Size
11.5 KB
Accession
0001104659-25-056838
Insider Transaction Report
Form 4
Meeker David P
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-06-03$4.59/sh+43,620$200,216→ 245,445 total - Sale
Common Stock
2025-06-03$65.04/sh−43,346$2,819,358→ 202,099 total - Sale
Common Stock
2025-06-03$65.60/sh−274$17,975→ 201,825 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-06-03−43,620→ 0 totalExercise: $4.59Exp: 2025-11-16→ Common Stock (43,620 underlying)
Footnotes (5)
- [F1]Includes 544 additional shares acquired under the Issuer's Employee Stock Purchase Plan.
- [F2]The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 plan adopted by the Reporting Person on March 3, 2025.
- [F3]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $64.59 to $65.58 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $65.60 to $65.61 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The stock option is fully vested.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001385155
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:16 PM ET
- Size
- 11.5 KB